This could be somehow in line with our findings since our patients who responded to the pharmacological treatment showed a general reduction in MCP-1 levels, although it did not reach statistical significance.
← all excerpts
Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients.
1
—
—